Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase

Hanna Sidjabat, Graeme Nimmo, Timothy Walsh, Enzo Binotto, Anthony Htin, Yoshiro Hayashi, Jian Li, Roger Nation, Narelle George, David Paterson

Research output: Contribution to journalComment / DebateResearchpeer-review

89 Citations (Scopus)

Abstract

Carbapenem resistance in Klebsiella pneumoniae is most notably due to the K. pneumoniae carbapenemase (KPC) beta-lactamase. In this report, we describe the occurrence of a newly described mechanism of carbapenem resistance, the NDM-1 beta-lactamase, in a patient who received medical attention (but was not hospitalized) in India.
Original languageEnglish
Pages (from-to)481 - 484
Number of pages4
JournalClinical Infectious Diseases
Volume52
Issue number4
DOIs
Publication statusPublished - 2011

Cite this

Sidjabat, H., Nimmo, G., Walsh, T., Binotto, E., Htin, A., Hayashi, Y., ... Paterson, D. (2011). Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase. Clinical Infectious Diseases, 52(4), 481 - 484. https://doi.org/10.1093/cid/ciq178
Sidjabat, Hanna ; Nimmo, Graeme ; Walsh, Timothy ; Binotto, Enzo ; Htin, Anthony ; Hayashi, Yoshiro ; Li, Jian ; Nation, Roger ; George, Narelle ; Paterson, David. / Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase. In: Clinical Infectious Diseases. 2011 ; Vol. 52, No. 4. pp. 481 - 484.
@article{a6270246c7014615827c0feecee6172e,
title = "Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase",
abstract = "Carbapenem resistance in Klebsiella pneumoniae is most notably due to the K. pneumoniae carbapenemase (KPC) beta-lactamase. In this report, we describe the occurrence of a newly described mechanism of carbapenem resistance, the NDM-1 beta-lactamase, in a patient who received medical attention (but was not hospitalized) in India.",
author = "Hanna Sidjabat and Graeme Nimmo and Timothy Walsh and Enzo Binotto and Anthony Htin and Yoshiro Hayashi and Jian Li and Roger Nation and Narelle George and David Paterson",
year = "2011",
doi = "10.1093/cid/ciq178",
language = "English",
volume = "52",
pages = "481 -- 484",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",

}

Sidjabat, H, Nimmo, G, Walsh, T, Binotto, E, Htin, A, Hayashi, Y, Li, J, Nation, R, George, N & Paterson, D 2011, 'Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase', Clinical Infectious Diseases, vol. 52, no. 4, pp. 481 - 484. https://doi.org/10.1093/cid/ciq178

Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase. / Sidjabat, Hanna; Nimmo, Graeme; Walsh, Timothy; Binotto, Enzo; Htin, Anthony; Hayashi, Yoshiro; Li, Jian; Nation, Roger; George, Narelle; Paterson, David.

In: Clinical Infectious Diseases, Vol. 52, No. 4, 2011, p. 481 - 484.

Research output: Contribution to journalComment / DebateResearchpeer-review

TY - JOUR

T1 - Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi metallo-alpha-lactamase

AU - Sidjabat, Hanna

AU - Nimmo, Graeme

AU - Walsh, Timothy

AU - Binotto, Enzo

AU - Htin, Anthony

AU - Hayashi, Yoshiro

AU - Li, Jian

AU - Nation, Roger

AU - George, Narelle

AU - Paterson, David

PY - 2011

Y1 - 2011

N2 - Carbapenem resistance in Klebsiella pneumoniae is most notably due to the K. pneumoniae carbapenemase (KPC) beta-lactamase. In this report, we describe the occurrence of a newly described mechanism of carbapenem resistance, the NDM-1 beta-lactamase, in a patient who received medical attention (but was not hospitalized) in India.

AB - Carbapenem resistance in Klebsiella pneumoniae is most notably due to the K. pneumoniae carbapenemase (KPC) beta-lactamase. In this report, we describe the occurrence of a newly described mechanism of carbapenem resistance, the NDM-1 beta-lactamase, in a patient who received medical attention (but was not hospitalized) in India.

U2 - 10.1093/cid/ciq178

DO - 10.1093/cid/ciq178

M3 - Comment / Debate

VL - 52

SP - 481

EP - 484

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 4

ER -